Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA.

Zangwill SD, Stamm KD, Hidestrand M, Tomita-Mitchell A, Mitchell ME.

J Heart Lung Transplant. 2019 Oct;38(10):1118-1120. doi: 10.1016/j.healun.2019.06.005. Epub 2019 Jun 28. No abstract available.

PMID:
31324442
2.

Metakaryotic cells linked to pediatric pulmonary vein stenosis.

Kirkpatrick EC, Mitchell ME, Thilly WG, Hidestrand P, Tomita-Mitchell A, Hidestrand M, Gostjeva EV.

Cardiovasc Pathol. 2019 Mar - Apr;39:51-53. doi: 10.1016/j.carpath.2018.12.005. Epub 2018 Dec 21. No abstract available.

PMID:
30660022
3.

Impact of MYH6 variants in hypoplastic left heart syndrome.

Tomita-Mitchell A, Stamm KD, Mahnke DK, Kim MS, Hidestrand PM, Liang HL, Goetsch MA, Hidestrand M, Simpson P, Pelech AN, Tweddell JS, Benson DW, Lough JW, Mitchell ME.

Physiol Genomics. 2016 Dec 1;48(12):912-921. doi: 10.1152/physiolgenomics.00091.2016. Epub 2016 Oct 27.

4.

Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid.

Hidestrand M, Tomita-Mitchell A, Hidestrand PM, Oliphant A, Goetsch M, Stamm K, Liang HL, Castleberry C, Benson DW, Stendahl G, Simpson PM, Berger S, Tweddell JS, Zangwill S, Mitchell ME.

J Am Coll Cardiol. 2014 Apr 1;63(12):1224-1226. doi: 10.1016/j.jacc.2013.09.029. Epub 2013 Oct 16. No abstract available.

5.

Human gene copy number spectra analysis in congenital heart malformations.

Tomita-Mitchell A, Mahnke DK, Struble CA, Tuffnell ME, Stamm KD, Hidestrand M, Harris SE, Goetsch MA, Simpson PM, Bick DP, Broeckel U, Pelech AN, Tweddell JS, Mitchell ME.

Physiol Genomics. 2012 May 1;44(9):518-41. doi: 10.1152/physiolgenomics.00013.2012. Epub 2012 Feb 7.

6.

Influence of temperature during transportation on cell-free DNA analysis.

Hidestrand M, Stokowski R, Song K, Oliphant A, Deavers J, Goetsch M, Simpson P, Kuhlman R, Ames M, Mitchell M, Tomita-Mitchell A.

Fetal Diagn Ther. 2012;31(2):122-8. doi: 10.1159/000335020. Epub 2012 Jan 19.

PMID:
22261730
7.

Non-invasive prenatal detection of trisomy 21 using tandem single nucleotide polymorphisms.

Ghanta S, Mitchell ME, Ames M, Hidestrand M, Simpson P, Goetsch M, Thilly WG, Struble CA, Tomita-Mitchell A.

PLoS One. 2010 Oct 8;5(10):e13184. doi: 10.1371/journal.pone.0013184.

8.

Sca-1-expressing nonmyogenic cells contribute to fibrosis in aged skeletal muscle.

Hidestrand M, Richards-Malcolm S, Gurley CM, Nolen G, Grimes B, Waterstrat A, Zant GV, Peterson CA.

J Gerontol A Biol Sci Med Sci. 2008 Jun;63(6):566-79.

9.

Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats.

Shankar K, Hidestrand M, Liu X, Chen JR, Haley R, Perrien DS, Skinner RA, Lumpkin CK Jr, Badger TM, Ronis MJ.

J Bone Miner Res. 2008 Mar;23(3):338-49.

10.

A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation.

Wahl EC, Liu L, Perrien DS, Aronson J, Hogue WR, Skinner RA, Hidestrand M, Ronis MJ, Badger TM, Lumpkin CK Jr.

Alcohol. 2006 Jul;39(3):159-67. Epub 2006 Oct 2.

PMID:
17127135
11.

Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.

Chen JR, Haley RL, Hidestrand M, Shankar K, Liu X, Lumpkin CK, Simpson PM, Badger TM, Ronis MJ.

J Pharmacol Exp Ther. 2006 Dec;319(3):1182-90. Epub 2006 Sep 13. Erratum in: J Pharmacol Exp Ther. 2007 Feb;320(2):960.

PMID:
16971503
12.

Physiologic and genomic analyses of nutrition-ethanol interactions during gestation: Implications for fetal ethanol toxicity.

Shankar K, Hidestrand M, Liu X, Xiao R, Skinner CM, Simmen FA, Badger TM, Ronis MJ.

Exp Biol Med (Maywood). 2006 Sep;231(8):1379-97.

PMID:
16946407
13.

Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6.

Keizers PH, Schraven LH, de Graaf C, Hidestrand M, Ingelman-Sundberg M, van Dijk BR, Vermeulen NP, Commandeur JN.

Biochem Biophys Res Commun. 2005 Dec 16;338(2):1065-74. Epub 2005 Oct 21.

PMID:
16269134
14.

Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats.

Shankar K, Hidestrand M, Haley R, Skinner RA, Hogue W, Jo CH, Simpson P, Lumpkin CK Jr, Aronson J, Badger TM, Ronis MJ.

Endocrinology. 2006 Jan;147(1):166-78. Epub 2005 Oct 20.

PMID:
16239303
15.

The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent.

Lussenburg BM, Keizers PH, de Graaf C, Hidestrand M, Ingelman-Sundberg M, Vermeulen NP, Commandeur JN.

Biochem Pharmacol. 2005 Oct 15;70(8):1253-61.

PMID:
16135359
16.

The effects of pregnancy on ethanol clearance.

Badger TM, Hidestrand M, Shankar K, McGuinn WD, Ronis MJ.

Life Sci. 2005 Sep 9;77(17):2111-26.

PMID:
15925387
17.
18.

Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.

Bogni A, Monshouwer M, Moscone A, Hidestrand M, Ingelman-Sundberg M, Hartung T, Coecke S.

Toxicol In Vitro. 2005 Aug;19(5):621-9.

PMID:
15893449
19.

Use of molecular simulation for mapping conformational CYP2E1 epitopes.

Vidali M, Hidestrand M, Eliasson E, Mottaran E, Reale E, Rolla R, Occhino G, Albano E, Ingelman-Sundberg M.

J Biol Chem. 2004 Dec 3;279(49):50949-55. Epub 2004 Sep 28.

20.

Identification of sequences responsible for intracellular targeting and membrane binding of rat CYP2E1 in yeast.

Neve EP, Hidestrand M, Ingelman-Sundberg M.

Biochemistry. 2003 Dec 16;42(49):14566-75.

PMID:
14661969
21.

Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.

Salonen JS, Nyman L, Boobis AR, Edwards RJ, Watts P, Lake BG, Price RJ, Renwick AB, Gómez-Lechón MJ, Castell JV, Ingelman-Sundberg M, Hidestrand M, Guillouzo A, Corcos L, Goldfarb PS, Lewis DF, Taavitsainen P, Pelkonen O.

Drug Metab Dispos. 2003 Sep;31(9):1093-102.

PMID:
12920164
22.

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.

Griskevicius L, Yasar U, Sandberg M, Hidestrand M, Eliasson E, Tybring G, Hassan M, Dahl ML.

Eur J Clin Pharmacol. 2003 Jun;59(2):103-9. Epub 2003 Apr 9.

PMID:
12684728
23.

Recent Progress in Drug Metabolism Research.

Aklillu E, Hidestrand M, Ingelman-Sundberg M, Malmebo S, Westlind A.

Drug News Perspect. 2002 Oct;15(8):528-534.

PMID:
12677192
24.

Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.

Aklillu E, Oscarson M, Hidestrand M, Leidvik B, Otter C, Ingelman-Sundberg M.

Mol Pharmacol. 2002 Mar;61(3):586-94.

PMID:
11854439
25.

The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase).

Hosseinpour F, Hidestrand M, Ingelman-Sundberg M, Wikvall K.

Biochem Biophys Res Commun. 2001 Nov 9;288(4):1059-63.

PMID:
11689019
26.

CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.

Hidestrand M, Oscarson M, Salonen JS, Nyman L, Pelkonen O, Turpeinen M, Ingelman-Sundberg M.

Drug Metab Dispos. 2001 Nov;29(11):1480-4.

PMID:
11602525
27.

Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.

Yasui-Furukori N, Hidestrand M, Spina E, Facciolá G, Scordo MG, Tybring G.

Drug Metab Dispos. 2001 Oct;29(10):1263-8.

PMID:
11560868
28.

Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems.

Pelkonen O, Myllynen P, Taavitsainen P, Boobis AR, Watts P, Lake BG, Price RJ, Renwick AB, Gómez-Lechón MJ, Castell JV, Ingelman-Sundberg M, Hidestrand M, Guillouzo A, Corcos L, Goldfarb PS, Lewis DF.

Xenobiotica. 2001 Jun;31(6):321-43.

PMID:
11513246
29.

Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.

Wennerholm A, Johansson I, Hidestrand M, Bertilsson L, Gustafsson LL, Ingelman-Sundberg M.

Pharmacogenetics. 2001 Jul;11(5):417-27. Erratum in: Pharmacogenetics 2001 Nov;11(8):743.

PMID:
11470994
30.

Role of CYP2C9 polymorphism in losartan oxidation.

Yasar U, Tybring G, Hidestrand M, Oscarson M, Ingelman-Sundberg M, Dahl ML, Eliasson E.

Drug Metab Dispos. 2001 Jul;29(7):1051-6.

PMID:
11408373
31.

Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.

Facciolá G, Hidestrand M, von Bahr C, Tybring G.

Eur J Clin Pharmacol. 2001 Mar;56(12):881-8.

PMID:
11317475
32.

An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant.

Andersson TB, Sjöberg H, Hoffmann KJ, Boobis AR, Watts P, Edwards RJ, Lake BG, Price RJ, Renwick AB, Gómez-Lechón MJ, Castell JV, Ingelman-Sundberg M, Hidestrand M, Goldfarb PS, Lewis DF, Corcos L, Guillouzo A, Taavitsainen P, Pelkonen O.

Drug Metab Dispos. 2001 May;29(5):712-20.

PMID:
11302938
33.

Cloning and expression of rat CYP2E1 in Saccharomyces cerevisiae: detection of genotoxicity of N-alkylformamides.

Del Carratore MR, Mezzatesta C, Hidestrand M, Neve P, Amato G, Gervasi PG.

Environ Mol Mutagen. 2000;36(2):97-104.

PMID:
11013407
34.

Characterization and functional analysis of two common human cytochrome P450 1B1 variants.

McLellan RA, Oscarson M, Hidestrand M, Leidvik B, Jonsson E, Otter C, Ingelman-Sundberg M.

Arch Biochem Biophys. 2000 Jun 1;378(1):175-81.

PMID:
10871058
35.

Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides.

Bylund J, Hidestrand M, Ingelman-Sundberg M, Oliw EH.

J Biol Chem. 2000 Jul 21;275(29):21844-9.

36.

A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

Oscarson M, Hidestrand M, Johansson I, Ingelman-Sundberg M.

Mol Pharmacol. 1997 Dec;52(6):1034-40.

PMID:
9415713

Supplemental Content

Loading ...
Support Center